论文部分内容阅读
东菱克栓酶是近年来治疗缺血性脑血管病的新药,现已被临床广泛应用,我科近年对住院的短暂性脑缺血病人进行东菱克栓酶及常规药物治疗的对比,现报道如下。1 临床资料和治疗方法 选择病例均经详细询问病史、神经系统检查及头部CT检查明确诊断为短暂性脑缺血发作病人。有下列情
It is a new drug for the treatment of ischemic cerebrovascular disease in recent years. It has been widely used clinically in recent years. In recent years, Report as follows now. A clinical data and treatment of selected cases were asked in detail history, neurological examination and head CT examination was diagnosed as transient ischemic attack patients. Have the following feelings